HGWM
GILD icon

Horst & Graben Wealth Management’s Gilead Sciences GILD Stock Holding History

Horst & Graben Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,276
Closed -$279K – 196
2025
Q4 		$279K Sell
2,276
-19
-0.8% -$2.31K 0.04% 147
2025
Q3 		$255K Buy
2,295
+47
+2% +$5.34K 0.04% 157
2025
Q2 		$249K Buy
2,248
+5
+0.2% +$532 0.04% 147
2025
Q1 		$251K Buy
+2,243
New +$231K 0.05% 136
2023
Q4 		– Sell
-4,486
Closed -$336K – 144
2023
Q3 		$336K Buy
4,486
+1,079
+32% +$83K 0.08% 99
2023
Q2 		$263K Buy
3,407
+21
+0.6% +$1.68K 0.06% 108
2023
Q1 		$281K Buy
3,386
+22
+0.7% +$1.82K 0.07% 103
2022
Q4 		$289K Buy
3,364
+21
+0.6% +$1.66K 0.08% 106
2022
Q3 		$206K Buy
3,343
+38
+1% +$2.4K 0.06% 120
2022
Q2 		$204K Buy
+3,305
New +$205K 0.06% 125
2022
Q1 		– Sell
-3,227
Closed -$234K – 140
2021
Q4 		$234K Buy
3,227
+30
+0.9% +$2.07K 0.06% 124
2021
Q3 		$223K Buy
3,197
+32
+1% +$2.25K 0.06% 123
2021
Q2 		$218K Buy
3,165
+4
+0.1% +$267 0.06% 122
2021
Q1 		$204K Buy
+3,161
New +$204K 0.06% 124
2020
Q3 		– Sell
-3,150
Closed -$242K – 109
2020
Q2 		$242K Buy
+3,150
New +$241K 0.11% 88

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Horst & Graben Wealth Management's GILD Position: Q1 2026 in Review

Horst & Graben Wealth Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 2,276 shares — an estimated $279K sold.

Horst & Graben Wealth Management first reported a position in GILD in Q2 2020 and held it in 15 quarters. The position peaked at $336K in Q3 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Horst & Graben Wealth Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Horst & Graben Wealth Management sold 2,276 Gilead Sciences shares in Q1 2026, an estimated $279K.
  • Horst & Graben Wealth Management first reported a position in Gilead Sciences in Q2 2020 and held it in 15 quarters.
  • Horst & Graben Wealth Management's Gilead Sciences position peaked at $336K in Q3 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Horst & Graben Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.